Mark Peakman

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

Diabetologia

Science translational medicine

King’s College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King’s College London Oct 01 2017

United Kingdom

Head of Department of Diabetes :: Faculty of Life Science & Medicine

King's College London

United Kingdom

Professor of Clinical Immunology :: Faculty of Life Sciences & Medicine

King's College Hospital Oct 01 1994

United Kingdom

Honorary Consultant Clinical Immunologist

King’s College Hospital

United Kingdom

Honorary Consultant Immunologist

King’s College School of Medicine & Dentistry

United Kingdom

Senior Lecturer in Immunology (HEFCE)

King's College London

United Kingdom

Reader in Immunology

Diabetes UK

United Kingdom

Senior Clinical Research Fellow

Children’s Hospital and University of Pittsburgh

United States

Research Assistant Professor in Immunogenetics

King’s College School of Medicine & Dentistry

United Kingdom

Lecturer (HEFCE) in Immunology

King's College Hospital

United Kingdom

Honorary Lecturer

King's College Hospital

United Kingdom

Honorary Senior Registrar

King’s College School of Medicine & Dentistry (KCSMD)

United Kingdom

Wellcome Trust Research Training Fellow, Department of Immunology

King's College Hospital

United Kingdom

Demonstrator (Senior House Officer and Registrar grade) in Pathology

University College Hospital, London

United Kingdom

House Surgeon, Professorial Unit

Royal United Hospital, Bath

United Kingdom

House Physician

Publications

Tommi Vatanen, Carine de Beaufort, Maria Loredana Marcovecchio, Lut Overbergh, Soren Brunak, Mark Peakman, Chantal Mathieu, Olli H Laitinen, null null
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study. Diabetologia (2024)
Robert Moulder, Tommi Välikangas, M Karoliina Hirvonen, Tomi Suomi, Caroline A Brorsson, Niina Lietzén, Sylvaine F A Bruggraber, Lut Overbergh, Professor David Dunger, Mark Peakman, Piotr J Chmura, Soren Brunak, Anke M Schulte, Chantal Mathieu, Olli H Laitinen, Laura L Elo, Riitta Lahesmaa, null null
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory. Diabetologia (2023)
Amir-Babak Sioofy-Khojine, Sarah J Richardson, Jonathan M Locke, Sami Oikarinen, Noora Nurminen, Antti-Pekka Laine, Kate Downes, Johanna Lempainen, John A Todd, Riitta Veijola, Jorma Ilonen, Olli H Laitinen, Noel G Morgan, Heikki Hyöty, Mark Peakman, Martin Eichmann
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage. Diabetologia 65 (10) (2022)
Sefina Arif, Iria Gomez-Tourino, Yogesh Kamra, Irma Pujol-Autonell, Emily Hanton, Timothy Tree, Daisy Melandri, Caroline Hull, Diane K Wherrett, Craig Beam, Bart O Roep, Anna Lorenc, Mark Peakman
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. Diabetologia 63 (6) (2020)
Mohammad Alhadj Ali, Yuk-Fun Liu, Sefina Arif, Danijela Tatovic, Hina Shariff, Vivienne B Gibson, Norkhairin Yusuf, Roman Baptista, Martin Eichmann, Nedyalko Petrov, Susanne Heck, Jennie Hsiu Mien Yang, Timothy I M Tree, Irma Pujol-Autonell, Lorraine Yeo, Lucas Baumard, Rachel Stenson, Alex Howell, Alison Clark, Zoe Boult, Jake Powrie, Laura Adams, Florence Susan Wong, Stephen Luzio, Gareth Dunseath, Kate Green, Alison O'Keefe, Graham Bayly, Natasha Thorogood, Robert Andrews, Nicola Leech, Frank Joseph, Sunil Nair, Susan Seal, HoYee Cheung, Craig A Beam, Robert Hills, Mark Peakman, Colin M Dayan
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Science translational medicine 9 (402) (2018)
Satveer K Mahil, Marika Catapano, Paola Di Meglio, Nick Dand, Helena Ahlfors, Ian M Carr, Catherine H Smith, Richard C Trembath, Mark Peakman, John Wright, Francesca D Ciccarelli, Jonathan N Barker, Francesca Capon
An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target. Science translational medicine 9 (411) (2018)

Mark Peakman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Peakman